BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 08 2025
0mins
Should l Buy ?
Source: PRnewswire
Conference Call Announcement: BrainStorm Cell Therapeutics Inc. will hold a conference call on August 14, 2025, at 8:30 AM ET to update shareholders on its financial results for Q2 2025, featuring key executives including the CEO and COO.
Company Overview: BrainStorm specializes in adult stem cell therapies for neurodegenerative diseases, particularly ALS, and is advancing its NurOwn® platform while also developing an exosome-based technology, with recent patent allowances enhancing its intellectual property portfolio.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
